Literature DB >> 29268654

Implementation of a prospective pregnancy registry for antiretroviral based HIV prevention trials.

Felix G Mhlanga1,2, Lisa Noguchi3, Jennifer E Balkus4,5,6, Samuel Kabwigu7, Rachel Scheckter8, Jeanna Piper9, Heather Watts10, Colin O'Rourke4, Kristine Torjesen8, Elizabeth R Brown4,11, Sharon L Hillier12, Richard Beigi12.   

Abstract

BACKGROUND: Safety data on pregnancy and fetal outcomes among women in HIV prevention trials are urgently needed to inform use of effective antiretroviral agents for HIV prevention. We describe an effective, efficient, and novel method to prospectively collect perinatal safety data concurrent with on-going parent clinical trials.
METHODS: The Microbicide Trials Network (MTN)-016 study is a multinational prospective pregnancy exposure registry designed to capture pregnancy and neonatal outcomes. Studies currently contributing data to this registry included phase I and II safety trials with planned exposures to candidate HIV prevention agents, as well as phase IIB and III efficacy trials capturing data on pregnancy and infant outcomes following inadvertent fetal exposure during study participation.
RESULTS: To date, participants from two phase I studies and two effectiveness trials have participated in MTN-016, resulting in 420 pregnant women and 381 infants enrolled. Infant retention has been high, with 329 of 381 (86%) infants completing the 12-month follow-up visit.
CONCLUSION: In a research setting context, it is feasible to establish and implement a prospective, multinational HIV chemoprophylaxis pregnancy registry that will generate pregnancy exposure data in a robust fashion.

Entities:  

Keywords:  ARV-chemoprophylaxis agents; HIV; congenital malformation; pregnancy; registry

Mesh:

Substances:

Year:  2017        PMID: 29268654      PMCID: PMC5995113          DOI: 10.1080/15284336.2017.1411419

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


  10 in total

1.  Pharmacokinetics and placental transfer of single-dose tenofovir 1% vaginal gel in term pregnancy.

Authors:  Richard Beigi; Lisa Noguchi; Teresa Parsons; Ingrid Macio; Ratiya P Kunjara Na Ayudhya; Jianmeng Chen; Craig W Hendrix; Benoît Mâsse; Megan Valentine; Jeanna Piper; D Heather Watts
Journal:  J Infect Dis       Date:  2011-09-19       Impact factor: 5.226

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.

Authors:  Jared M Baeten; Thesla Palanee-Phillips; Elizabeth R Brown; Katie Schwartz; Lydia E Soto-Torres; Vaneshree Govender; Nyaradzo M Mgodi; Flavia Matovu Kiweewa; Gonasagrie Nair; Felix Mhlanga; Samantha Siva; Linda-Gail Bekker; Nitesha Jeenarain; Zakir Gaffoor; Francis Martinson; Bonus Makanani; Arendevi Pather; Logashvari Naidoo; Marla Husnik; Barbra A Richardson; Urvi M Parikh; John W Mellors; Mark A Marzinke; Craig W Hendrix; Ariane van der Straten; Gita Ramjee; Zvavahera M Chirenje; Clemensia Nakabiito; Taha E Taha; Judith Jones; Ashley Mayo; Rachel Scheckter; Jennifer Berthiaume; Edward Livant; Cindy Jacobson; Patrick Ndase; Rhonda White; Karen Patterson; Donna Germuga; Beth Galaska; Katherine Bunge; Devika Singh; Daniel W Szydlo; Elizabeth T Montgomery; Barbara S Mensch; Kristine Torjesen; Cynthia I Grossman; Nahida Chakhtoura; Annalene Nel; Zeda Rosenberg; Ian McGowan; Sharon Hillier
Journal:  N Engl J Med       Date:  2016-02-22       Impact factor: 91.245

4.  Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission.

Authors:  S Palmer; V Boltz; N Martinson; F Maldarelli; G Gray; J McIntyre; J Mellors; L Morris; J Coffin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

5.  Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.

Authors:  Paige L Williams; Marilyn J Crain; Cenk Yildirim; Rohan Hazra; Russell B Van Dyke; Kenneth Rich; Jennifer S Read; Emma Stuard; Mobeen Rathore; Hermann A Mendez; D Heather Watts
Journal:  JAMA Pediatr       Date:  2015-01       Impact factor: 16.193

6.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.

Authors:  Jeanne M Marrazzo; Gita Ramjee; Barbra A Richardson; Kailazarid Gomez; Nyaradzo Mgodi; Gonasagrie Nair; Thesla Palanee; Clemensia Nakabiito; Ariane van der Straten; Lisa Noguchi; Craig W Hendrix; James Y Dai; Shayhana Ganesh; Baningi Mkhize; Marthinette Taljaard; Urvi M Parikh; Jeanna Piper; Benoît Mâsse; Cynthia Grossman; James Rooney; Jill L Schwartz; Heather Watts; Mark A Marzinke; Sharon L Hillier; Ian M McGowan; Z Mike Chirenje
Journal:  N Engl J Med       Date:  2015-02-05       Impact factor: 91.245

7.  Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women.

Authors:  Annalene Nel; Neliëtte van Niekerk; Saidi Kapiga; Linda-Gail Bekker; Cynthia Gama; Katherine Gill; Anatoli Kamali; Philip Kotze; Cheryl Louw; Zonke Mabude; Nokuthula Miti; Sylvia Kusemererwa; Hugo Tempelman; Hannelie Carstens; Brid Devlin; Michelle Isaacs; Mariëtte Malherbe; Winel Mans; Jeremy Nuttall; Marisa Russell; Smangaliso Ntshele; Marlie Smit; Leonard Solai; Patrick Spence; John Steytler; Kathleen Windle; Maarten Borremans; Sophie Resseler; Jens Van Roey; Wim Parys; Tony Vangeneugden; Ben Van Baelen; Zeda Rosenberg
Journal:  N Engl J Med       Date:  2016-12-01       Impact factor: 91.245

Review 8.  Pregnancy incidence and risk factors among women participating in vaginal microbicide trials for HIV prevention: systematic review and meta-analysis.

Authors:  Alfred Musekiwa; Evans Muchiri; Samuel O M Manda; Henry G Mwambi
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

Review 9.  Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis.

Authors:  Alison L Drake; Anjuli Wagner; Barbra Richardson; Grace John-Stewart
Journal:  PLoS Med       Date:  2014-02-25       Impact factor: 11.069

10.  A randomized safety and pharmacokinetic trial of daily tenofovir 1% gel in term and near-term pregnancy.

Authors:  Richard H Beigi; Lisa M Noguchi; Elizabeth Montgomery; Joseph Biggio; Craig W Hendrix; Mark A Marzinke; James Y Dai; Jason Pan; Ratiya Kunjara Na Ayudhya; Jill L Schwartz; Karen Isaacs; Jeanna M Piper; D Heather Watts
Journal:  J Int AIDS Soc       Date:  2016-09-21       Impact factor: 5.396

  10 in total
  3 in total

1.  Pregnancy and Infant Outcomes Among Women Using the Dapivirine Vaginal Ring in Early Pregnancy.

Authors:  Bonus Makanani; Jennifer E Balkus; Yuqing Jiao; Lisa M Noguchi; Thesla Palanee-Phillips; Yamikani Mbilizi; Jothi Moodley; Kenneth Kintu; Krishnaveni Reddy; Samuel Kabwigu; Nitesha Jeenariain; Ishana Harkoo; Nyaradzo Mgodi; Jeanna Piper; Helen Rees; Rachel Scheckter; Richard Beigi; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-15       Impact factor: 3.731

2.  Social harms in female-initiated HIV prevention method research: state of the evidence.

Authors:  Elizabeth T Montgomery; Sarah T Roberts; Annalene Nel; Mariette Malherbe; Kristine Torjesen; Katherine Bunge; Devika Singh; Jared M Baeten; Jeanne Marrazzo; Z Mike Chirenje; Samuel Kabwigu; Richard Beigi; Sharon A Riddler; Zakir Gaffour; Krishnaveni Reddy; Leila E Mansoor; Gonasagrie Nair; Kusbashni Woeber; Jayajothi Moodley; Nitesha Jeenarain; Samantha Siva; Logashvari Naidoo; Vaneshree Govender; Thesla Palanee-Phillips
Journal:  AIDS       Date:  2019-11-15       Impact factor: 4.177

3.  Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?

Authors:  Lee Fairlie; Catriona Waitt; Shahin Lockman; Michelle Moorhouse; Elaine J Abrams; Polly Clayden; Marta Boffito; Saye Khoo; Helen Rees; Amandine Cournil; Willem Francois Venter; Celicia Serenata; Matthew Chersich
Journal:  J Int AIDS Soc       Date:  2019-09       Impact factor: 5.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.